|
|
||||||||
Mount Sinai School of Medicine, Department of Community Medicine, New York, NY 10029.
To gain insight into corporate activities regarding the identification of occupational carcinogens earlier in this century, the actions of one industry, the asbestos industry, were reviewed. This industry, in concert with many of its insurers, systematically developed and then suppressed information on the carcinogenicity of asbestos. The development of warnings for those exposed to the asbestos was delayed. As a result, millions of workers were exposed to the carcinogen and hundreds of thousands died. These events are placed into the context of similar activities in other industries during this time.
This article has been cited by other articles:
![]() |
L. A Bero, T. Montini, K. Bryan-Jones, and C. Mangurian Science in regulatory policy making: case studies in the development of workplace smoking restrictions Tob. Control, December 1, 2001; 10(4): 329 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Landrigan Asbestos -- Still a Carcinogen N. Engl. J. Med., May 28, 1998; 338(22): 1618 - 1619. [Full Text] |
||||
![]() |
D. E. Barnes and L. A. Bero Industry-Funded Research and Conflict of Interest: An Analysis of Research Sponsored by the Tobacco Industry through the Center for Indoor Air Research Journal of Health Politics Policy and Law, September 1, 1996; 21(3): 515 - 542. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |